Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

GlaxoSmithKline PLC (OTC Pink - Current Information:GLAXF)

18.30
Delayed Data
As of Dec 09
 +0.10 / +0.55%
Today’s Change
18.16
Today|||52-Week Range
22.98
-12.44%
Year-to-Date
Asset Sales, New Projects Fuel 6.7% Yield
Dec 07 / GuruFocus News - Paid Partner Content
Merck's Keytruda Gets Priority Review for Hodgkin Lymphoma
Dec 02 / Zacks.com - Paid Partner Content
Pfizer Takes $106 Million Fine from U.K. for Price Hike of Epilepsy Drug
Dec 07 / TheStreet.com - Paid Partner Content
Here's the Best Dividend Stock in Big Pharma
Dec 01 / MotleyFool.com - Paid Partner Content
Has GlaxoSmithKline Finally Turned the Corner?
Dec 06 / MotleyFool.com - Paid Partner Content
Merck: Keytruda's Priority Review for New Cancer Indication
Nov 29 / Zacks.com - Paid Partner Content
Robust Pipeline Supports 5.5% Dividend Yield
Dec 05 / GuruFocus News - Paid Partner Content
Glaxo (GSK) Files Regulatory Application for Shingrix in EU
Nov 28 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close18.20
Today’s open18.34
Day’s range18.30 - 18.34
Volume2,405
Average volume (3 months)3,563
Market cap$88.7B
Dividend yield5.41%
Data as of 1:31pm ET, 12/09/2016

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratio--
Price/Sales--
Price/Book--

Competitors

No competitors data available.

Financials

Next reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)--
Annual profit (last year)--
Net profit margin--

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
No executives to display
Corporate headquarters
--, --

Forecasts


Search for Jobs